In Friday's The Good, The Bad, The Ugly: The biggest IPO ever makes its NYSE debut; U.S. taxes encourage foreign buyers; and tax inversion only goes one way.» Read More
We overcame transport and weather issues in North American, says Andrew Liveris, President, Chairman & CEO of Dow Chemical, breaking down his company's first quarter results of $0.79 EPS on revenues of $14.46 billion.
It's not a dirty little secret anymore, says Heather Thomson, Yummie by Heather Thomson founder, discussing how her company is redefining the shapewear industry and carving out a piece of the market.
Investors need to separate new tech from old tech, says Christopher Wolfe, Merrill Lynch, sharing his views on whether there's a tech bubble brewing. And Mark Haefele, UBS Wealth Management, weighs in.
Chris Caso, Susquehanna Financial Group analyst, shares his outlook on Apple in the second half. Apple needs to show shareholders the next new thing, says Caso.
CNBC's Meg Tirrell digs into the friendly and hostile M&A action taking place in pharmaceuticals, including a deal between Novartis and GlaxoSmithKline, and Valeant Pharmaceuticals bid for Allergan.
Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell.
CNBC's Jane Wells reports on the good and bad of El Nino if it develops near South American mines, and coffee and cocoa.
McDonald's reported Q1 EPS of $1.21 on revenue of $6.7 billion. RJ Hottovy of Morningstar, still sees value in the stock.
Citi investors are in St. Louis today for the bank's annual shareholder meeting. CNBC's Kayla Tausche provides insight into the day's schedule.
Valeant Pharmaceuticals offered $48.30 share cash, as well as 0.83 shares for Allergan. CNBC's Meg Tirrell provides insight.
The megabillion-dollar deals with Novartis also allow GlaxoSmithKline to "significantly expand" its world-leading vaccine business, GSK's CEO tells CNBC.
McDonald's is reporting Q1 EPS of $1.21 on revenue of $6.700 billion, with the "Squawk Box" crew.
Chris Baggini of Turner Titan Fund, explains his top three stock picks for investors right now. He says Facebook's advertising model is "very strong."
BTIG media and tech analyst Rich Greenfield, questions why some of the bandwidth burden should or shouldn't fall on Netflix.
Comcast reported $0.68 ex-items on revenue of $17.408 billion in Q1. BTIG media and tech analyst Rich Greenfield, discusses cable network advertising, and explains the opportunities that could arise from the Time Warner Cable and Comcast deal.
Eli Lilly Chairman & CEO John Lechleiter discusses his business' expansion of its animal health unit with the acquisition of Novartis' animal health business.
Discussing current market conditions, and how the activist investor is changing the conversation in the board room, with Julian Emanuel, UBS, and Charles Kantor, Neuberger Berman.
Comcast is reporting $0.68 ex-items on revenue of $17.408 billion, with the "Squawk Box" crew.
GlaxoSmithKline CEO Sir Andrew Witty, discusses the benefit to shareholders from his company's acquisition of Novartis' vaccination business, as well as its oncology unit.
GlaxoSmithKline CEO Sir Andrew Witty, explains the large portfolio of vaccinations his company provides, and the value added from the company's acquisition of Novartis' vaccination business.
Get the best of CNBC in your inbox